News for QIAGEN N.V. (QIA.DE)

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Incyte (Nasdaq: INCY) today announced a new global collaboration to develop a novel diagnostic pane

QIAGEN (QGEN) and Incyte (INCY) form a collaboration to develop companion diagnostics for myeloproliferative neoplasms (MPNs). The new multimodal panel

Qiagen N.V.

QIAGEN (QGEN) partners with ID Solutions to expand its digital PCR oncology research portfolio. The collaboration aims to enhance the availability of di

Qiagen has a relatively well-diversified portfolio across four segments. Find out my recommendation on QGEN stock here.

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has signed a definitive agreement to acquire [url="]Genoox[/url], a provider of AI-powere

Qiagen N.V. (NYSE:QGEN) Q1 2025 Earnings Conference Call May 8, 2025 9:00 AM ETCompany ParticipantsJohn Gilardi - Vice President, Head of Corporate...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a series of product and partnership updates designed to strengthen its portfolio for ca

QIAGEN debuts new QIAseq panels for comprehensive genomic profiling at AACR 2025. Partnerships with Element Biosciences and Myriad Genetics enhance canc

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that plans are advancing to launch three new sample preparation instruments during 2025 and

Ad hoc Announcement according to Art. 17 Market Abuse RegulationQIAGEN announces strong preliminary Q1 2025 results and updates full-year 2025 adjusted earnings

We recently compiled a list of the 10 Cash-Rich Mid Cap Stocks To Buy Now. In this article, we are going to take a look at where Qiagen N.V.

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has filed a complaint against bioMérieux S.A. (EPA: BIM) for patent infringeme

Qiagen stock faces market pressure due to recent NIH funding concerns, despite strong financials and a diverse product portfolio. Click to read why QGEN is a Hold.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

Operator: Ladies and gentlemen, thank you for standing by. I am Taryn, your Global Meet call operator. Welcome, and thank you for joining the Q4 2024 earnings conference call webcast.

Qiagen N.V. (NYSE:QGEN) Q4 2024 Earnings Conference Call February 6, 2025 10:00 AM ETCompany ParticipantsJohn Gilardi – Vice President, Head of Corporate...

The following slide deck was published by Qiagen N.V.

QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the fourth quarter 2024. Press release date / time: Wednesday